Literature DB >> 3922769

Granulocyte migration in ulcerative colitis.

S H Saverymuttu, V S Chadwick, H J Hodgson.   

Abstract

Although histologically relapses in ulcerative colitis are characterized by an intense granulocyte infiltrate, there is evidence both from in vitro function tests and skin window migration studies in vivo that there is defective granulocyte function in ulcerative colitis. We have recently developed a method for non invasively monitoring granulocyte migration to sites of inflammation using indium-111-labelled granulocytes, and have used this technique in fifteen patients with ulcerative colitis. In all fifteen cases there was rapid migration of indium-111-labelled granulocytes to inflamed bowel within 10 min of return of the labelled cells. This study provides no support for a significant granulocyte migration defect in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922769     DOI: 10.1111/j.1365-2362.1985.tb00145.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

1.  Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

Authors:  E A Lobos; P Sharon; W F Stenson
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

Review 2.  Neutrophil-Epithelial Interactions: A Double-Edged Sword.

Authors:  Charles A Parkos
Journal:  Am J Pathol       Date:  2016-04-12       Impact factor: 4.307

Review 3.  Pathobiology of neutrophil-epithelial interactions.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

4.  Expression of Lewis-a glycans on polymorphonuclear leukocytes augments function by increasing transmigration.

Authors:  Jennifer C Brazil; Ronen Sumagin; Sean R Stowell; Goo Lee; Nancy A Louis; Richard D Cummings; Charles A Parkos
Journal:  J Leukoc Biol       Date:  2017-06-09       Impact factor: 4.962

Review 5.  Alterations of the mucosal immune system in inflammatory bowel disease.

Authors:  R P MacDermott
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

6.  Mucosal factors inducing neutrophil movement in ulcerative colitis: the role of interleukin 8 and leukotriene B4.

Authors:  A T Cole; B J Pilkington; J McLaughlan; C Smith; M Balsitis; C J Hawkey
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

7.  Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis.

Authors:  E Aghdassi; J Carrier; J Cullen; M Tischler; J P Allard
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

8.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.

Authors:  H C Reinecker; M Steffen; T Witthoeft; I Pflueger; S Schreiber; R P MacDermott; A Raedler
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 9.  The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.

Authors:  Jennifer C Brazil; Nancy A Louis; Charles A Parkos
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

10.  Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.

Authors:  S Nikolaus; J Bauditz; P Gionchetti; C Witt; H Lochs; S Schreiber
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.